Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients

NCT06685653 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

65

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

BIOLOGICAL: Adebrelimab+RGL-270
BIOLOGICAL: Adebrelimab+RGL-270/single RGL-270

Sponsor

Nanjing Tianyinshan Hospital

Collaborators

[object Object]